WFA of San Diego’s GSK GSK Stock Holding History

WFA of San Diego’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-80	Closed	-$2.81K	–	199
2022 Q4	$2.81K	Buy	+80	New	+$2.67K	﹤0.01%	429
2022 Q3	–	Sell	-80	Closed	-$4K	–	196
2022 Q2	$4K	Buy	+80	New	+$4.42K	﹤0.01%	331

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WFA of San Diego's GSK Position: Q1 2023 in Review

WFA of San Diego sold out of GSK (GSK) in Q1 2023, closing a stake of 80 shares — an estimated $2.81K sold.

WFA of San Diego first reported a position in GSK in Q2 2022 and held it in 2 quarters. The position peaked at $4K in Q2 2022. 809 funds tracked by Wall St. Rank hold GSK as of Q1 2023.

WFA of San Diego reported no remaining GSK position as of Q1 2023 after selling out during the quarter.
WFA of San Diego sold 80 GSK shares in Q1 2023, an estimated $2.81K.
WFA of San Diego first reported a position in GSK in Q2 2022 and held it in 2 quarters.
WFA of San Diego's GSK position peaked at $4K in Q2 2022.
809 funds tracked by Wall St. Rank held GSK as of Q1 2023.

Based on WFA of San Diego's 13F filing for Q1 2023, filed 17 Apr 2023.